Crescent Biopharma CBIO
NASDAQ CBIO
$14.26 -0.33 (-2.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Crescent Biopharma (CBIO) posted Depreciation & Amortization (CF) of $66,000 for Q2 2026, compared with $2,000 a year earlier and up 3.1% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Crescent Biopharma was $212,000; for FY2025, it came in at $84,000, up 138.8% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -20.9% (FY2020 to FY2025).
  • In prior years, Crescent Biopharma's Depreciation & Amortization (CF) was $35,174 in FY2024 (-77.1%), $153,301 in FY2023 (-26.0%), $207,145 in FY2022 (-21.7%) and $264,600 in FY2021 (-2.3%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q3 2021.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2021, with growth of 1.3%; the weakest was Q2 2025, with a decline of 83.9%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $64,000 (Q1 2026), $54,000 (Q4 2025) and $28,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Crescent Biopharma 404.96 Mn -302.33 Mn - 66,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66,000.00
Mar 31, 2026 64,000.00
Dec 31, 2025 54,000.00
Sep 30, 2025 28,000.00
Jun 30, 2025 2,000.00
Sep 30, 2024 8,131.00
Jun 30, 2024 12,423.00
Mar 31, 2024 14,620.00
Dec 31, 2023 23,297.00
Sep 30, 2023 42,747.00
Jun 30, 2023 43,419.00
Mar 31, 2023 43,839.00
Dec 31, 2022 45,718.00
Sep 30, 2022 47,347.00
Jun 30, 2022 54,773.00
Mar 31, 2022 59,308.00
Dec 31, 2021 61,643.00
Sep 30, 2021 67,385.00
Jun 30, 2021 67,485.00
Mar 31, 2021 68,088.00
API Access

Crescent Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CBIO&period=max&api_key=YOUR_API_KEY